Cleared Traditional

ABL300 ACID BASE LABORATORY (K844295) - FDA 510(k) Clearance

Class II Hematology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K844295 · Radiometer America, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1984
Decision
34d
Days
Class 2
Risk

K844295 is an FDA 510(k) clearance for the ABL300 ACID BASE LABORATORY. Classified as Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph (product code CHL), Class II - Special Controls.

Submitted by Radiometer America, Inc. (Westlake, US). The FDA issued a Cleared decision on December 10, 1984 after a review of 34 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1120 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Radiometer America, Inc. devices

Submission Details

510(k) Number K844295 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 06, 1984
Decision Date December 10, 1984
Days to Decision 34 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 113d · This submission: 34d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1120
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - CHL Electrode Measurement, Blood-gases (pco2, Po2) And Blood Ph

All 47
Devices cleared under the same product code (CHL) and FDA review panel - the closest regulatory comparables to K844295.
CIBA CORNING MODEL 238 PH/ BLOOD GAS ANALYZER
K904188 · Ciba Corning Diagnostics Corp. · Sep 1990
IL1400, BGELECTROLYTE ANALYZER
K890827 · Instrumentation Laboratory CO · Jun 1989
CIBA CORNING MODEL 278 PH/BLOOD GAS SYSTEM
K865036 · Ciba Corning Diagnostics Corp. · Mar 1987
CORNING 170 PH/BLOOD GAS ANALYZER
K823570 · Corning Medical & Scientific · Dec 1982
IL 1302 PH BLOOD GAS ANALYZER
K821483 · Instrumentation Laboratory CO · Jun 1982
IL MODEL 1301, PH BLOOD GAS SYSTEM
K820744 · Instrumentation Laboratory CO · Apr 1982